C M Bidwell & Associates LTD Pfizer Inc Transaction History

C M Bidwell & Associates LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $112,369 - $133,235	-2,415 Reduced 28.62%	6,022 $316,000
Q1 2022 Apr 29, 2022	SELL	$45.75 - $56.69 $9,058 - $11,224	-198 Reduced 2.29%	8,437 $437,000
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $356,798 - $528,893	8,635 New	8,635 $510,000
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $362,425 - $469,960	-11,155 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$36.98 - $41.52 $383,852 - $430,977	10,380 Added 1339.35%	11,155 $483,000
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $29,814 - $33,991	775 New	775 $34,000

3,219

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $165B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.